2-ethyl-butyric acid isopropylamide

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2-ethyl-butyric acid isopropylamide
• 英文别名: 2-Aethyl-N-isopropyl-butyramid；2-Aethyl-buttersaeure-isopropylamid；2-ethyl-N-propan-2-ylbutanamide
• 化学式: C₉H₁₉NO
• mdl: MFCD03381414
• 分子量: 157.256
• InChiKey: BJMPKTLNWGBMIU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  11
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.888
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  草酰氯 、 2-ethyl-butyric acid isopropylamide 、 苯 生成 4,4-diethyl-1-isopropyl-pyrrolidine-2,3,5-trione
  参考文献：
  名称：

  Trialkylpyrrolidinetriones

  摘要：

  DOI：

  10.1021/ja01168a057
• 作为产物：
  描述：

  3-Ethyl-2-[(propan-2-yl)amino]pent-2-enenitrile 生成 2-ethyl-butyric acid isopropylamide
  参考文献：
  名称：

  KIMPE N. DE; VERHE R.; BUYCK L. DE; CHYS J.; SCHAMP N., J. ORG. CHEM., 1978, 43, NO 13, 2670-2672

  摘要：

  DOI：

文献信息

• [EN] MACROCYCLIC COMPOUNDS AS PROTEASOME INHIBITORS<br/>[FR] COMPOSÉS MACROCYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS DU PROTÉASOME
  申请人：UNIV CORNELL

  公开号：WO2019075259A1

  公开（公告）日：2019-04-18

  The compounds of the present invention are represented by the following compounds having Formula I and Formula (I'): where the substituents R1, R2, R2', R3, R4, R5, R', R", X, Y, and Z are as defined herein and where the substituents R1, R2, R3, R4, R5, R', R", X, Y, and Z are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.

  本发明的化合物由具有以下式I和式(I')的化合物表示，其中取代基R1、R2、R2'、R3、R4、R5、R'、R"、X、Y和Z如本文所定义，取代基R1、R2、R3、R4、R5、R'、R"、X、Y和Z如本文所定义。这些化合物用于治疗细菌感染、寄生虫感染、真菌感染、癌症、免疫紊乱、自身免疫性疾病、神经退行性疾病和紊乱、炎症性疾病，或肌肉萎缩症，或用于为移植的器官或组织提供免疫抑制。
• Antiviral agents and uses thereof
  申请人：Griffith University

  公开号：US10028938B2

  公开（公告）日：2018-07-24

  The present invention relates to compounds which are found to exhibit an antiviral effect. The compounds are modulators of the activity of the viral haemagglutinin and/or neuraminidase enzymes.

  本发明涉及具有抗病毒作用的化合物。这些化合物是病毒血凝素和/或神经氨酸酶活性的调节剂。
• Compositions and methods for inhibition of the JAK pathway
  申请人：Rigel Pharmaceuticals, Inc.

  公开号：US10556891B2

  公开（公告）日：2020-02-11

  Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful.

  本文公开了式 I 的化合物、含有这些化合物的组合物，以及这些化合物和组合物用于治疗调节 JAK 通路或抑制 JAK 激酶（尤其是 JAK 2 和 JAK3）具有治疗作用的疾病的方法。
• TRIOXANE DIMERS HAVING HIGH ANTICANCER AND LONG-LASTING ANTIMALARIAL ACTIVITIES
  申请人：Posner Gary H.

  公开号：US20090291923A1

  公开（公告）日：2009-11-26

  The invention provides novel trioxane dimers having formulae III, IV or V: methods for their preparation, pharmaceutical compositions containing these compounds, and methods for treating cancer and/or malaria using these compounds and compositions.
• COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
  申请人：Rigel Pharmaceuticals, Inc.

  公开号：US20170158683A1

  公开（公告）日：2017-06-08

  Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful. Also disclosed are methods of making the compounds.